Aug 7, 2025· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2025-N-0816-0025
Comments from the Consumer Healthcare Products Association (CHPA)
FDANonrulemakingFDA-2025-N-0816
Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments
RIN
—
Last modified
Aug 15, 2025
Comment window
closed 348d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Aug 7, 2025 and Aug 7, 2025. 0 other organizations filed here. The comment window closed 348d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%